Valuation: Circio Holding ASA

Market Cap 310.15Cr 33Cr 30Cr 28Cr 25Cr 47Cr 3.19TCr 48Cr 332.05Cr 132.26Cr 1.67TCr 125.64Cr 122.99Cr 5.3TCr P/E 2026 *
-31.3x
P/E 2027 * -34.3x
Enterprise Value 241.25Cr 26Cr 23Cr 22Cr 20Cr 37Cr 2.48TCr 37Cr 258.29Cr 102.88Cr 1.3TCr 98Cr 96Cr 4.12TCr EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
74.23%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
1 week-2.81%
Current month-6.32%
1 month-6.49%
3 months+20.00%
6 months+8.69%
Current year+791.75%
1 week 10.26
Extreme 10.26
11.76
1 month 10.2
Extreme 10.2
11.78
Current year 0.98
Extreme 0.978
15.7
1 year 0.91
Extreme 0.908
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
185.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/11/21 Exercice

Chief Executive Officer

1,20,000 0.1386%
19/05/21 Buy

Director

21,299 0.0246%
03/12/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-1.69%-2.81%+1,004.26%+67.42% 33Cr
+0.65%-3.36%+36.98%+60.50% 6.41TCr
+1.63%+3.19%+12.81%+84.82% 5.55TCr
+1.03%+1.81%+13.08%+105.33% 5.3TCr
-1.23%-0.27%+27.43%+56.68% 4.6TCr
+0.59%-1.97%+19.02%+100.81% 4.25TCr
+1.30%+0.70%+225.74%+929.95% 4.04TCr
+0.64%-3.95%+11.15%+45.57% 3.23TCr
-0.66%+45.37%+107.53%+93.77% 3.45TCr
-2.72%-0.44%+23.18%-10.77% 2.42TCr
Average -0.12%+3.28%+148.12%+153.41% 3.93TCr
Weighted average by Cap. +0.35%+3.48%+50.76%+160.72%

Financials

2026 *2027 *
Net sales - -
Net income -8.5Cr -91.76L -82.33L -76.11L -68.93L -1.29Cr -87Cr -1.3Cr -9.1Cr -3.62Cr -46Cr -3.44Cr -3.37Cr -145.18Cr -9.1Cr -98.23L -88.14L -81.49L -73.8L -1.38Cr -94Cr -1.4Cr -9.74Cr -3.88Cr -49Cr -3.69Cr -3.61Cr -155.42Cr
Net Debt -69Cr -7.44Cr -6.67Cr -6.17Cr -5.59Cr -10Cr -708.38Cr -11Cr -74Cr -29Cr -370.68Cr -28Cr -27Cr -1.18TCr -60Cr -6.47Cr -5.8Cr -5.36Cr -4.86Cr -9.08Cr -615.85Cr -9.19Cr -64Cr -26Cr -322.26Cr -24Cr -24Cr -1.02TCr
Projected Income Statement - Annual - Circio Holding ASA
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
29/26/29 NOK 10.46 -1.69% 28,07,467
28/26/28 NOK 10.64 -7.80% 74,62,287
27/26/27 NOK 11.54 +2.67% 26,12,963
26/26/26 NOK 11.24 +3.69% 24,76,013
23/26/23 NOK 10.84 +1.50% 16,18,829

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Circio Holding ASA
  1. Stock Market
  2. Stocks
  3. TRVX Stock